Databases

研究者向けデータベース

Jenger sumstats一覧 Case-Control GWAS

IMSが公開しているヒトゲノムデータや要約統計量データ (sumstats) の一覧 (2020/8/15 更新)

2020/8/5 時点

この表はスクロールできます→

Name Case Ctrl PMID URL
Atrial Fibrillation 8,180 [M=5,713, F=2,467] 28,612 [M=11,223, F=17,389] 28416822 http://jenger.riken.jp/result
Rheumatoid Arthritis (Asian) 3,636 15,554
Rheumatoid Arthritis (Asian ChrX) 3,161 15,032
Rheumatoid Arthritis (European) 2,843 5,540
Rheumatoid Arthritis (European ChrX) 3,654 8,367
Rheumatoid Arthritis (TransEthnic) 3,636 15,554
Rheumatoid Arthritis (TransEthnic ChrX) 3,654 8,367
Open-angle glaucoma (autosomes, all) 3,980 [M=1,997, F=1,983] 18,815 [ M=7,817, F=10,998] 29452408 http://jenger.riken.jp/result
Open-angle glaucoma (X-chromosome, male) 1,997 7,817
Open-angle glaucoma (X-chromosome, female) 1,983 10,998
Colorectal Cancer 6,692 27,178 29471430 http://jenger.riken.jp/result
Type 2 Diabetes 36,614 155,150 30718926 http://jenger.riken.jp/result
Smoking behaviors : Smoking initiation (autosome, all) 83,810 81,626 31089300 http://jenger.riken.jp/result
Smoking behaviors : Smoking initiation (autosome, male) 67,773 21,905
Smoking behaviors : Smoking initiation (X-chromosome, male) 67,773 21,905
Smoking behaviors : Smoking initiation (autosome, female) 16,077 59,721
Smoking behaviors : Smoking initiation (X-chromosome, female) 16,077 59,721
Smoking behaviors : Smoking cessation (autosome, all) 43,163 32,884
Smoking behaviors : Smoking cessation (autosome, male) 36,787 24,909
Smoking behaviors : Smoking cessation (X-chromosome, male) 36,787 24,909
Smoking behaviors : Smoking cessation (autosome, female) 6,376 7,975
Smoking behaviors : Smoking cessation (X-chromosome, female) 6,376 7,975
Adolescent idiopathic scoliosis (all) 5,327 73,884 31417091 http://jenger.riken.jp/result
Adolescent idiopathic scoliosis (female) 5,004 33,679
Arrhythmia 17,861 [M=11,525, F=6,336] 194,592 [M=97,822, F=96,770] 28553958 http://jenger.riken.jp/result
Arrhythmia(sex stratified) 17,861 [M=11,525, F=6,336] 194,592 [M=97,822, F=96,770]
Asthma 8,216 [M=3,932, F=4,284] 201,592 [M=103,089, F=98,503]
Asthma(sex stratified) 8,216 [M=3,932, F=4,284] 201,592 [M=103,089, F=98,503]
Atopic dermatitis 2,385 [M=1,262, F=1,123] 209,651 [M=107,862, F=101,789]
Atopic dermatitis(sex stratified) 2,385 [M=1,262, F=1,123] 209,651 [M=107,862, F=101,789]
Biliary tract cancer 339 [M=211, F=128] 195,745 [M=97,655, F=98,090]
Biliary tract cancer(sex stratified) 339 [M=211, F=128] 195,745 [M=97,655, F=98,090]
Cataract 24,622 [M=11,641, F=12,981] 187,831 [M=97,706, F=90,125]
Cataract(sex stratified) 24,622 [M=11,641, F=12,981] 187,831 [M=97,706, F=90,125]
Cerebral aneurysm 2,820 [M=1,002, F=1,818] 192,383 [M=97,455, F=94,928]
Cerebral aneurysm(sex stratified) 2,820 [M=1,002, F=1,818] 192,383 [M=97,455, F=94,928]
Cervical cancer 605 [M=0, F=605] 89,731 [M=0, F=89,731]
Chronic hepatitis B 1,394 [M=878, F=516] 211,059 [M=108,469, F=102,590]
Chronic hepatitis B(sex stratified) 1,394 [M=878, F=516] 211,059 [M=108,469, F=102,590]
Chronic hepatitis C 5,794 [M=3,159, F=2,635] 206,659 [M=106,188, F=100,471]
Chronic hepatitis C(sex stratified) 5,794 [M=3,159, F=2,635] 206,659 [M=106,188, F=100,471]
Chronic obstructive pulmonary disease 3,315 [M=2,855, F=460] 201,592 [M=103,089, F=98,503]
Chronic obstructive pulmonary disease(sex stratified) 3,315 [M=2,855, F=460] 201,592 [M=103,089, F=98,503]
Cirrhosis 2,184 [M=1,347, F=837] 210,269 [M=108,000, F=102,269]
Cirrhosis(sex stratified) 2,184 [M=1,347, F=837] 210,269 [M=108,000, F=102,269]
Colorectal cancer 7,062 [M=4,496, F=2,566] 195,745 [M=97,655, F=98,090]
Colorectal cancer(sex stratified) 7,062 [M=4,496, F=2,566] 195,745 [M=97,655, F=98,090]
Congestive heart failure 9,413 [M=5,904, F=3,509] 203,040 [M=103,443, F=99,597]
Congestive heart failure(sex stratified) 9,413 [M=5,904, F=3,509] 203,040 [M=103,443, F=99,597]
Drug eruption 430 [M=230, F=200] 209,651 [M=107,862, F=101,789]
Drug eruption(sex stratified) 430 [M=230, F=200] 209,651 [M=107,862, F=101,789]
Endometrial cancer 999 [M=0, F=999] 89,731 [M=0, F=89,731]
Endometriosis 734 [M=0, F=734] 102,372 [M=0, F=102,372]
Epilepsy 2,143 [M=1,266, F=877] 210,310 [M=108,081, F=102,229]
Epilepsy(sex stratified) 2,143 [M=1,266, F=877] 210,310 [M=108,081, F=102,229]
Esophageal cancer 1,300 [M=1,132, F=168] 195,745 [M=97,655, F=98,090]
Esophageal cancer(sex stratified) 1,300 [M=1,132, F=168] 195,745 [M=97,655, F=98,090]
Gastric cancer 6,563 [M=4,885, F=1,678] 195,745 [M=97,655, F=98,090]
Gastric cancer(sex stratified) 6,563 [M=4,885, F=1,678] 195,745 [M=97,655, F=98,090]
Glaucoma 5,761 [M=2,770, F=2,991] 206,692 [M=106,577, F=100,115]
Glaucoma(sex stratified) 5,761 [M=2,770, F=2,991] 206,692 [M=106,577, F=100,115]
Graves’ disease 2,176 [M=597, F=1,579] 210,277 [M=108,750, F=101,527]
Graves’ disease(sex stratified) 2,176 [M=597, F=1,579] 210,277 [M=108,750, F=101,527]
Hematological malignancy 1,236 [M=701, F=535] 211,217 [M=108,646, F=102,571]
Hematological malignancy(sex stratified) 1,236 [M=701, F=535] 211,217 [M=108,646, F=102,571]
Interstitial lung disease 806 [M=495, F=311] 211,647 [M=108,852, F=102,795]
Interstitial lung disease(sex stratified) 806 [M=495, F=311] 211,647 [M=108,852, F=102,795]
Ischemic stroke 17,671 [M=11,081, F=6,590] 192,383 [M=97,455, F=94,928]
Ischemic stroke(sex stratified) 17,671 [M=11,081, F=6,590] 192,383 [M=97,455, F=94,928]
Keloid 812 [M=323, F=489] 211,641 [M=109,024, F=102,617]
Keloid(sex stratified) 812 [M=323, F=489] 211,641 [M=109,024, F=102,617]
Lung cancer 4,050 [M=2,710, F=1,340] 208,403 [M=106,637, F=101,766]
Lung cancer(sex stratified) 4,050 [M=2,710, F=1,340] 208,403 [M=106,637, F=101,766]
Nephrotic syndrome 957 [M=583, F=374] 211,496 [M=108,764, F=102,732]
Nephrotic syndrome(sex stratified) 957 [M=583, F=374] 211,496 [M=108,764, F=102,732]
Osteoporosis 7,788 [M=696, F=7,092] 204,665 [M=108,651, F=96,014]
Osteoporosis(sex stratified) 7,788 [M=696, F=7,092] 204,665 [M=108,651, F=96,014]
Ovarian cancer 720 [M=0, F=720] 89,731 [M=0, F=89,731]
Pancreatic cancer 442 [M=288, F=154] 195,745 [M=97,655, F=98,090]
Pancreatic cancer(sex stratified) 442 [M=288, F=154] 195,745 [M=97,655, F=98,090]
Periodontal disease 3,219 [M=1,415, F=1,804] 209,234 [M=107,932, F=101,302]
Periodontal disease(sex stratified) 3,219 [M=1,415, F=1,804] 209,234 [M=107,932, F=101,302]
Peripheral artery disease 3,593 [M=2,784, F=809] 208,860 [M=106,563, F=102,297]
Peripheral artery disease(sex stratified) 3,593 [M=2,784, F=809] 208,860 [M=106,563, F=102,297]
Pollinosis 5,746 [M=2,460, F=3,286] 206,707 [M=106,887, F=99,820]
Pollinosis(sex stratified) 5,746 [M=2,460, F=3,286] 206,707 [M=106,887, F=99,820]
Prostate cancer 5,408 [M=5,408, F=0] 103,939 [M=103,939, F=0]
Pulmonary tuberculosis 549 [M=387, F=162] 211,904 [M=108,960, F=102,944]
Pulmonary tuberculosis(sex stratified) 549 [M=387, F=162] 211,904 [M=108,960, F=102,944]
Rheumatoid arthritis 4,199 [M=874, F=3,325] 208,254 [M=108,473, F=99,781]
Rheumatoid arthritis(sex stratified) 4,199 [M=874, F=3,325] 208,254 [M=108,473, F=99,781]
Type 2 diabetes 40,250 [M=25,705, F=14,545] 170,615 [M=82,774, F=87,841]
Type 2 diabetes(sex stratified) 40,250 [M=25,705, F=14,545] 170,615 [M=82,774, F=87,841]
Urolithiasis 6,638 [M=4,996, F=1,642] 205,815 [M=104,351, F=101,464]
Urolithiasis(sex stratified) 6,638 [M=4,996, F=1,642] 205,815 [M=104,351, F=101,464]
Uterine fibroids 5,954 [M=0, F=5,954] 95,010 [M=0, F=95,010]
hepatocellular carcinoma 1,866 [M=1,384, F=482] 195,745 [M=97,655, F=98,090]
hepatocellular carcinoma(sex stratified) 1,866 [M=1,384, F=482] 195,745 [M=97,655, F=98,090]
Breast cancer 5,552 [M=0, F=5,552] 89,731 [M=0, F=89,731]
Coronary artery disease 29,319 [M=21,611, F=7,708] 183,134 [M=87,736, F=95,398]
Coronary artery disease(sex stratified) 29,319 [M=21,611, F=7,708] 183,134 [M=87,736, F=95,398]